Gene · 406962
Papers2,086
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,086
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Candidate biomarkers of EV-microRNA in detecting REM sleep behavior disorder and Parkinson's disease. | NPJ Parkinsons Dis | 2024 | 38200052 | PubTator, text mining | PubMed |
| Identification of key genes in chronic intermittent hypoxia-induced lung cancer progression based on transcriptome sequencing. | BMC Cancer | 2024 | 38183079 | PubTator, text mining | PubMed |
| RNA m6A methylation regulators in liver cancer. | Cancer Cell Int | 2024 | 38166832 | PubTator, text mining | PubMed |
| Corrigendum to "TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis" [Biochem. Biophys. Res. Commun. 491 (2) (2017) 552-557]. | Biochem Biophys Res Commun | 2024 | 38044221 | PubTator, text mining | PubMed |
| miR-186 regulates epithelial-mesenchymal transformation to promote nasopharyngeal carcinoma metastasis by targeting ZEB1. | Braz J Otorhinolaryngol | 2024 | 37989078 | PubTator, text mining | PubMed |
| Splicing factor ESRP1 derived circ_0068162 promotes the progression of oral squamous cell carcinoma via the miR-186/JAG axis. | Carcinogenesis | 2024 | 37966490 | PubTator, text mining | PubMed |
| Exosome regulation of immune response mechanism: Pros and cons in immunotherapy. | Bioact Mater | 2024 | 37927901 | PubTator, text mining | PubMed |
| N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation. | Gastric Cancer | 2024 | 37897508 | PubTator, text mining | PubMed |
| Genetic and epigenetic targets of natural dietary compounds as anti-Alzheimer's agents. | Neural Regen Res | 2024 | 37843220 | PubTator, text mining | PubMed |
| Oncogenic MORC2 in cancer development and beyond. | Genes Dis | 2024 | 37692502 | PubTator, text mining | PubMed |
| Antitumor Immunity: Role of NK Cells and Extracellular Vesicles in Cancer Immunotherapy. | Curr Issues Mol Biol | 2023 | 38248313 | PubTator, text mining | PubMed |
| Immunoregulatory functions and therapeutic potential of natural killer cell-derived extracellular vesicles in chronic diseases. | Front Immunol | 2023 | 38239346 | PubTator, text mining | PubMed |
| Downregulation of γ-Catenin by miR-195-5p Inhibits Colon Cancer Progression, Regulating Desmosome Function. | Int J Mol Sci | 2023 | 38203664 | PubTator, text mining | PubMed |
| Biological, pathological, and multifaceted therapeutic functions of exosomes to target cancer. | Oncol Res | 2023 | 38188673 | PubTator, text mining | PubMed |
| Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence. | Asian J Pharm Sci | 2023 | 38161784 | PubTator, text mining | PubMed |
| CRNDE: A Pivotal Oncogenic Long Non-Coding RNA in Cancers. | Yale J Biol Med | 2023 | 38161583 | PubTator, text mining | PubMed |
| Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients. | Front Immunol | 2023 | 38152407 | PubTator, text mining | PubMed |
| Shake It Up Baby Now: The Changing Focus on TWIST1 and Epithelial to Mesenchymal Transition in Cancer and Other Diseases. | Int J Mol Sci | 2023 | 38139368 | PubTator, text mining | PubMed |
| The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges. | Mol Ther Oncolytics | 2023 | 38130701 | PubTator, text mining | PubMed |
| Association between erythrocyte membrane fatty acids and gut bacteria in obesity-related cognitive dysfunction. | AMB Express | 2023 | 38123761 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406962/papers?page=4